PTIX - Protagenic Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
486
881
717
418
Selling General and Administrative
1,387
1,433
1,648
1,411
Total Operating Expenses
1,873
2,314
2,365
1,829
Operating Income or Loss
-1,873
-2,314
-2,365
-1,829
Interest Expense
-
-
0
7
Total Other Income/Expenses Net
80
-246
92
-440
Income Before Tax
-1,791
-2,558
-2,260
-2,276
Income Tax Expense
0
0
-
-
Income from Continuing Operations
-1,791
-2,558
-2,260
-2,276
Net Income
-1,791
-2,558
-2,260
-2,276
Net Income available to common shareholders
-1,791
-2,558
-2,260
-2,276
Reported EPS
Basic
-
-0.25
-0.22
-0.43
Diluted
-
-0.25
-0.22
-0.43
Weighted average shares outstanding
Basic
-
10,261
10,261
5,306
Diluted
-
10,261
10,261
5,306
EBITDA
-
-2,314
-2,259
-2,268